Table 2. Comparison of myocardial enzymes and adverse events of two groups .

	Cilostazol + rosuvastatin group (86 patients)	Rosuvastatin group (86 patients)	p value
Baseline hs-CRP	9.89 ± 1.12	10.93 ± 1.61	0.54
Post-procedure hs-CRP	15.16 ± 1.63	15.21 ± 1.49	0.56
Baseline Tn I (ng/ml)	0.023 ± 0.003	0.019 ± 0.004	0.052
Post-procedure 6 hour Tn I	0.10 ± 0.02	0.12 ± 0.02	0.41
Post-procedure 12 hour Tn I	0.25 ± 0.04	0.36 ± 0.08	0.48
Post-procedure 48 hour Tn I	0.25 ± 0.05	0.42 ± 0.09	0.84
Baseline CK-MB (U/L)	16.32 ± 0.78	21.84 ± 3.83	0.77
Post-procedure 6 hour CK-MB	14.63 ± 0.76	17.79 ± 2.55	0.97
Post-procedure 12 hour CK-MB	16.01 ± 0.79	20.04 ± 2.75	0.71
Post-procedure 48 hour CK-MB	13.79 ± 0.85	17.97 ± 2.75	0.46
1. month MACE n (%)	1 (1.2)	1 (1.2)	1.00
Major bleeding n (%)	1 (1.2)	1 (1.2)	1.00
Minor bleeding n (%)	2 (2.3)	1 (1.2)	0.50

CK-MB, creatine kinase – myocardial band; hs-CRP, high sensitivity C-reactive protein; MACE, major adverse cardiac events; Tn I, troponin I.